anti-DLL3 ADC (IntoCell/Y-Biologics)

N/A

Report date: 2025/03/14 16:35:05

Base Information

Drug Nameanti-DLL3 ADC (IntoCell/Y-Biologics)
Drug Alias Nameanti-DLL3 antibody-drug conjugate (IntoCell/Y-Biologics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionDelta-like protein 3 modulators
TargetsDelta-like protein 3
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIntoCell Inc
China Registration ClassN/A

Develop Information

Active CompaniesIntoCell IncY-biologics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A